Ranibizumab joins laser surgery as diabetic macular edema treatment
August 16th 2012The FDA has approved once-monthly, 0.3-mg ranibizumab injection (Lucentis, Genentech) for treatment of diabetic macular edema (DME), making it the first and only drug approved by the agency for the condition. The standard of care for DME for the past 25 years has been laser surgery.
Glaucoma imaging takes its place in clinical practice
August 1st 2012Use of imaging in clinical practice offers clinicians a number of advantages for following patients with glaucoma, perhaps most importantly the ability sometimes to detect damage before it is apparent on fundus photographs, objective rates of glaucoma progression, and the ability to predict the patients who are at high risk of functional impairment. Robert N. Weinreb, MD, talked about how imaging and clinical practice are a good fit.
Humidity has modest effect on best-corrected visual acuity
July 1st 2012Procedure room humidity appears to have a small effect on best-corrected visual acuity outcomes after corneal laser refractive surgery, but variations in humidity or temperature do not appear to affect uncorrected visual acuity outcomes, the incidence of diffuse lamellar keratitis after LASIK, or need for enhancement after myopic LASIK or LASEK.